Minneapolis-based Medtronic has recalled Palindrome and Mahurkar hemodialysis catheters, which the FDA deemed a class 1 recall, the highest level.
The recall is due to a catheter hub defect that could lead to a leaking condition. There has been one complaint but no reports of death or injuries with the defect, according to the FDA.
The affected catheters are implanted and used in hemodialysis, apheresis and infusion.
Medtronic notified customers June 8 of the defect.